Furthermore, it was recently reported that subsets of p53-deficient human cancer cells and tumors exhibit chronic overexpression of nuclear p21Cip1/Waf1, which in turn leads to escape from senescence, deregulation of replication licensing, replication stress, genomic instability and chemotherapy resistance [37]. The gene discussed is TP53; the disease is cancer.